Literature DB >> 11250107

Effects of initial particle size on the tableting properties of L-lysine monohydrochloride dihydrate powder.

C Sun1, D J Grant.   

Abstract

L-lysine monohydrochloride (LMH) dihydrate was crystallized and the resulting powder was sieved to obtain various size fractions. The influence of other factors, such as crystallinity and crystal shape, was minimized by using the same batch of crystals. Compression of smaller particles at low compaction pressures resulted in tablets of greater porosity. The differences in porosity decreased with increasing compaction pressure. At the same compaction pressure, smaller particles formed tablets of greater tensile strength. However, fragmentation of the larger particles tended to equalize the particle size and reduce its influence. The differences were reduced for particles larger than 710 microm. For crystals of all size fractions, tensile strength increased with increasing compaction pressure. The tensile strength increased more rapidly for smaller crystals. Tensile strength decreased exponentially with increasing porosity for all fractions. The dependence of tensile strength on porosity is explained in term of tablet structure. Yield strength, calculated from 'out-of-die' Heckel analysis, increased with increasing particle size.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250107     DOI: 10.1016/s0378-5173(00)00701-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.

Authors:  Shing Fung Chow; Miles Chen; Limin Shi; Albert H L Chow; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2012-02-23       Impact factor: 4.200

2.  Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.

Authors:  Wasfy M Obeidat; Ali Nokhodchi; Hatim Alkhatib
Journal:  AAPS PharmSciTech       Date:  2015-02-28       Impact factor: 3.246

3.  Effect of particle size on in-die and out-of-die compaction behavior of ranitidine hydrochloride polymorphs.

Authors:  Kailas S Khomane; Arvind K Bansal
Journal:  AAPS PharmSciTech       Date:  2013-07-30       Impact factor: 3.246

4.  Continuous Single-Step Wet Granulation with Integrated in-Barrel-Drying.

Authors:  Adrian Schmidt; Hans de Waard; Peter Kleinebudde; Markus Krumme
Journal:  Pharm Res       Date:  2018-06-25       Impact factor: 4.200

Review 5.  Microstructure of Tablet-Pharmaceutical Significance, Assessment, and Engineering.

Authors:  Changquan Calvin Sun
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.200

6.  Influence of crystal structure on the compaction properties of n-alkyl 4-hydroxybenzoate esters (parabens).

Authors:  Yushi Feng; David J W Grant
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

7.  Mechanisms of Crystal Plasticization by Lattice Water.

Authors:  Chenguang Wang; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2022-03-17       Impact factor: 4.200

Review 8.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

9.  Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight.

Authors:  Changquan Sun; David J W Grant
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

10.  The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants.

Authors:  Samy Yassin; Daniel J Goodwin; Andrew Anderson; Juraj Sibik; D Ian Wilson; Lynn F Gladden; J Axel Zeitler
Journal:  J Pharm Sci       Date:  2015-06-12       Impact factor: 3.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.